Shirakawa Yukitoshi, Kuratani Toru, Shimamura Kazuo, Torikai Kei, Sakamoto Tomohiko, Shijo Takayuki, Sawa Yoshiki
Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Eur J Cardiothorac Surg. 2014 Feb;45(2):298-304; discussion 304. doi: 10.1093/ejcts/ezt391. Epub 2013 Aug 2.
Conventional total aortic arch repair is a high-risk procedure, particularly for high-risk patients. Although endovascular treatment of aortic arch aneurysm is a recently induced procedure, only a few cases are indicated and outcomes are questionable. Here, we report on the early and short-term results of our surgical procedure, i.e. hybrid arch repair with supra-aortic debranching and endografting into the ascending aorta.
Of the 514 patients who underwent arch repairs from 1997 to March 2012, 40 (28 males; mean age 74.4 years) were high-risk patients for whom hybrid arch repair of the ascending aortic landing zone was performed. Aortic pathologies included 31 degenerative aneurysms (including two ruptures), three type A dissections and four type B dissections. We performed supra-aortic debranching from the ascending aorta and endografting into the ascending aorta in 28 patients (including 10 patients with graft replacements and 3 patients with banding of the ascending aorta). For the 12 patients with an ascending aorta diameter of <36 mm, the chimney graft technique into the innominate artery was performed.
The 30-day mortality rate was 3%. Postoperative complications were as follows: stroke (0 patient), haemodialysis (1), prolonged mechanical ventilation (2) and spinal cord ischaemia (1). There were one early type I and two type II endoleaks. The mean follow-up duration was 15.5 months, during which freedom from aorta-related death and aortic events were 91 and 89% at 3 years.
We achieved satisfactory early and short-term results with hybrid arch repair into the ascending aorta. Our findings suggest that hybrid repair into the ascending aorta may be a viable option for high-risk patients with aortic arch pathologies.
传统的全主动脉弓修复术是一种高风险手术,尤其是对于高危患者。尽管主动脉弓动脉瘤的血管内治疗是最近开展的手术,但仅有少数病例适用,其疗效也存在疑问。在此,我们报告我们的手术方法,即升主动脉去分支及腔内修复的杂交弓修复术的早期和短期结果。
在1997年至2012年3月期间接受弓部修复的514例患者中,40例(28例男性;平均年龄74.4岁)为高危患者,对其进行了升主动脉着陆区的杂交弓修复。主动脉病变包括31例退行性动脉瘤(包括2例破裂)、3例A型夹层和4例B型夹层。我们对28例患者进行了升主动脉去分支及升主动脉腔内修复(包括10例人工血管置换和3例升主动脉缩窄)。对于12例升主动脉直径<36 mm的患者,采用烟囱支架技术植入无名动脉。
30天死亡率为3%。术后并发症如下:卒中(0例患者)、血液透析(1例)、机械通气时间延长(2例)和脊髓缺血(1例)。有1例早期I型内漏和2例II型内漏。平均随访时间为15.5个月,3年时主动脉相关死亡和主动脉事件的无发生率分别为91%和89%。
我们通过升主动脉杂交弓修复术取得了满意的早期和短期结果。我们的研究结果表明,升主动脉杂交修复术可能是患有主动脉弓病变的高危患者的一个可行选择。